71 related articles for article (PubMed ID: 25583782)
1. Study uncovers mutation involved in two cancers.
Cancer Discov; 2015 Jan; 5(1):5-6. PubMed ID: 25583782
[TBL] [Abstract][Full Text] [Related]
2. Novel Wnt signaling and other pathway inhibitors in the colorectal cancer genomic landscape era.
Roukos DH; Ziogas DE; Papaloukas C; Baltogiannis G
Future Oncol; 2012 Nov; 8(11):1373-6. PubMed ID: 23148609
[No Abstract] [Full Text] [Related]
3. RNF43 is frequently mutated in colorectal and endometrial cancers.
Giannakis M; Hodis E; Jasmine Mu X; Yamauchi M; Rosenbluh J; Cibulskis K; Saksena G; Lawrence MS; Qian ZR; Nishihara R; Van Allen EM; Hahn WC; Gabriel SB; Lander ES; Getz G; Ogino S; Fuchs CS; Garraway LA
Nat Genet; 2014 Dec; 46(12):1264-6. PubMed ID: 25344691
[TBL] [Abstract][Full Text] [Related]
4. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin.
Abdel-Rahman WM; Kalinina J; Shoman S; Eissa S; Ollikainen M; Elomaa O; Eliseenkova AV; Bützow R; Mohammadi M; Peltomäki P
Hum Mutat; 2008 Mar; 29(3):390-7. PubMed ID: 18165946
[TBL] [Abstract][Full Text] [Related]
5. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
6. Drug development: Mix and match.
Scudellari M
Nature; 2015 May; 521(7551):S12-4. PubMed ID: 25970452
[No Abstract] [Full Text] [Related]
7. Role of canonical Wnt signaling in endometrial carcinogenesis.
Dellinger TH; Planutis K; Tewari KS; Holcombe RF
Expert Rev Anticancer Ther; 2012 Jan; 12(1):51-62. PubMed ID: 22149432
[TBL] [Abstract][Full Text] [Related]
8. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
McDonald SL; Silver AR
Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
[TBL] [Abstract][Full Text] [Related]
9. Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620.
Pooja T; Karunagaran D
Eur J Pharmacol; 2014 Nov; 742():55-64. PubMed ID: 25205133
[TBL] [Abstract][Full Text] [Related]
10. Frequency and nature of hMSH6 germline mutations in Polish patients with colorectal, endometrial and ovarian cancers.
Suchy J; Kurzawski G; Jakubowska K; Rać ME; Safranow K; Kładny J; Rzepka-Górska I; Chosia M; Czeszyńska B; Oszurek O; Scott RJ; Lubiński J
Clin Genet; 2006 Jul; 70(1):68-70. PubMed ID: 16813607
[No Abstract] [Full Text] [Related]
11. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
12. New target genes in endometrial tumors show a role for the estrogen-receptor pathway in microsatellite-unstable cancers.
Ferreira AM; Tuominen I; Sousa S; Gerbens F; van Dijk-Bos K; Osinga J; Kooi KA; Sanjabi B; Esendam C; Oliveira C; Terpstra P; Hardonk M; van der Sluis T; Zazula M; Stachura J; van der Zee AG; Hollema H; Sijmons RH; Aaltonen LA; Seruca R; Hofstra RM; Westers H
Hum Mutat; 2014 Dec; 35(12):1514-23. PubMed ID: 25231886
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets and targeted therapeutics in endometrial cancer.
Weigelt B; Banerjee S
Curr Opin Oncol; 2012 Sep; 24(5):554-63. PubMed ID: 22581357
[TBL] [Abstract][Full Text] [Related]
14. No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer.
Vahteristo P; Ojala S; Tamminen A; Tommiska J; Sammalkorpi H; Kiuru-Kuhlefelt S; Eerola H; Aaltonen LA; Aittomäki K; Nevanlinna H
J Med Genet; 2005 Apr; 42(4):e22. PubMed ID: 15805151
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells.
Götze S; Coersmeyer M; Müller O; Sievers S
Int J Oncol; 2014 Oct; 45(4):1715-23. PubMed ID: 25050608
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R; Chalastanis A; Colas C; El Bchiri J; Mercier D; Schreurs AS; Simon V; Svrcek M; Zaanan A; Borie C; Buhard O; Capel E; Zouali H; Praz F; Muleris M; Fléjou JF; Duval A
Bull Cancer; 2008 Jan; 95(1):121-32. PubMed ID: 18230578
[TBL] [Abstract][Full Text] [Related]
17. High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumors.
Ferreira AM; Tuominen I; van Dijk-Bos K; Sanjabi B; van der Sluis T; van der Zee AG; Hollema H; Zazula M; Sijmons RH; Aaltonen LA; Westers H; Hofstra RM
Hum Mutat; 2014 Dec; 35(12):1442-5. PubMed ID: 25196364
[TBL] [Abstract][Full Text] [Related]
18. Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study.
Konecny GE; Finkler N; Garcia AA; Lorusso D; Lee PS; Rocconi RP; Fong PC; Squires M; Mishra K; Upalawanna A; Wang Y; Kristeleit R
Lancet Oncol; 2015 Jun; 16(6):686-94. PubMed ID: 25981814
[TBL] [Abstract][Full Text] [Related]
19. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium.
Ouyang H; Furukawa T; Abe T; Kato Y; Horii A
Clin Cancer Res; 1998 Apr; 4(4):1071-4. PubMed ID: 9563904
[TBL] [Abstract][Full Text] [Related]
20. [Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors].
Nilbert M; Grönberg H; Lindblom A
Lakartidningen; 2002 Aug; 99(34):3296-300. PubMed ID: 12362848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
